- Home
- USCB vs PACB Comparison
USCB vs PACB Comparison
Compare USCB & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USCB
- PACB
- Stock Information
- Founded
- USCB 2002
- PACB 2000
- Country
- USCB United States
- PACB United States
- Employees
- USCB N/A
- PACB N/A
- Industry
- USCB Major Banks
- PACB Biotechnology: Laboratory Analytical Instruments
- Sector
- USCB Finance
- PACB Industrials
- Exchange
- USCB Nasdaq
- PACB Nasdaq
- Market Cap
- USCB 353.0M
- PACB 364.2M
- IPO Year
- USCB 2021
- PACB 2010
- Fundamental
- Price
- USCB $18.95
- PACB $1.54
- Analyst Decision
- USCB Buy
- PACB Buy
- Analyst Count
- USCB 2
- PACB 13
- Target Price
- USCB $18.25
- PACB $2.79
- AVG Volume (30 Days)
- USCB 19.9K
- PACB 14.1M
- Earning Date
- USCB 01-23-2025
- PACB 02-13-2025
- Dividend Yield
- USCB 1.32%
- PACB N/A
- EPS Growth
- USCB 47.62
- PACB N/A
- EPS
- USCB 1.24
- PACB N/A
- Revenue
- USCB $79,519,000.00
- PACB $154,014,000.00
- Revenue This Year
- USCB N/A
- PACB $22.84
- Revenue Next Year
- USCB $7.69
- PACB $30.91
- P/E Ratio
- USCB $15.28
- PACB N/A
- Revenue Growth
- USCB 25.02
- PACB N/A
- 52 Week Low
- USCB $10.25
- PACB $1.16
- 52 Week High
- USCB $21.86
- PACB $6.09
- Technical
- Relative Strength Index (RSI)
- USCB 49.36
- PACB 45.60
- Support Level
- USCB $18.86
- PACB $1.27
- Resistance Level
- USCB $19.41
- PACB $2.06
- Average True Range (ATR)
- USCB 0.70
- PACB 0.21
- MACD
- USCB -0.09
- PACB 0.03
- Stochastic Oscillator
- USCB 23.28
- PACB 34.18
About USCB USCB Financial Holdings Inc.
USCB Financial Holdings Inc is a community bank. Through its network of branches and its online banking platform, it offers customers a wide range of financial products and services such as Personal and Business Checking, Savings, Credit Cards, and Real Estate Loans.
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.